Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 5 of 24

HVP AMPLATZER™ PFO Occluder Post Approval Study

The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval...

Ethan Korngold MD
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
  • TOC Gateway - Heart Clinic

A 3-arm, Multicenter, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ADS-5102 Amantadine Extended Release Capsules in Multiple Sclerosis Patients With Walking Impairment

This is a multicenter, 3-arm, randomized, placebo-controlled, double-blind, parallel-group study of ADS-5102 (amantadine extended release [ER]...

Kiren Kresa-Reahl MD
  • Providence St. Vincent Medical Center

Measurement of Relaxin in the Serum and Cerebrospinal Fluid of Subjects With and Without the Relapsing Form of Multiple Sclerosis

This study will evaluate relaxin (RLX) levels in patients with multiple sclerosis. Key Eligibilities: -Females 18 to 45 years of age.-Patients with...

Stanley Cohan, M.D., Ph.D.
  • Providence St. Vincent Medical Center

North American Registry for Care and Research in Multiple Sclerosis (NARCRMS)

The North American Registry for Care and Research in Multiple Sclerosis (NARCRMS) is a physician/clinician based registry and longitudinal database...

Stanley Cohan, M.D., Ph.D.
  • Providence St. Vincent Medical Center

BIP - Long-term, Prospective, Multinational, Parallel-cohort Study Monitoring Safety in Patients With MS Newly Started With Fingolimod Once Daily or Treated With Another Approved Disease-modifying Therapy

The purpose of this world-wide prospective parallel-cohort study in patients with relapsing forms of Multiple Sclerosis, either newly treated with...

Stanley Cohan, M.D., Ph.D.
  • Providence St. Vincent Medical Center
« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 5 of 24